Sergey Terushkin, MD, FACS Key Takeaways Turn on the news or scroll through TikTok, and you will see it: Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) are being hailed as the end of obesity. And in many ways, they are
These therapies, primarily administered as subcutaneous injectables for ease of at-home use, act by mimicking the native GLP1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon release, lowering HbA1c levels, and promoting weight loss - all while carrying a minimal risk of hypoglycemia when used alone
References Ellingson, K
Your body naturally produces GHK-Cu, but levels decline by 60% between age 20 and age 60 (from 200 ng/mL to 80 ng/mL)
Biocon Biologics posted full-year revenue of Rs 9,017 crore in FY25, with 15% year-on-year growth, and four of its biosimilars each recording sales of $200 million during the year